The mesoeconomics of abortion: A scoping review and analysis of the economic effects of abortion on health systems.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
01
2020
accepted:
08
07
2020
entrez:
4
11
2020
pubmed:
5
11
2020
medline:
19
12
2020
Statut:
epublish
Résumé
Despite the high incidence of abortion around the globe, we lack synthesis of the known economic consequences of abortion care and abortion policies at the mesoeconomic level (i.e. health systems and communities). This scoping review examines the mesoeconomic costs, benefits, impacts, and values of abortion care and policies. Searches were conducted in eight electronic databases. We conducted the searches and application of inclusion/exclusion criteria using the PRISMA extension for Scoping Reviews. For inclusion, studies must have examined at least one of the following outcomes: costs, benefits, impacts, and value of abortion care or abortion policies. Quantitative and qualitative data were extracted for descriptive statistics and thematic analysis. Of the 150 included mesoeconomic studies, costs to health systems are the most frequently reported mesoeconomic outcome (n = 116), followed by impacts (n = 40), benefits (n = 17), and values (n = 11). Within health facilities and health systems, the costs of providing abortion services vary greatly, particularly given the range with which researchers identify and cost services. Financial savings can be realized while maintaining or even improving quality of abortion services. Adapting to changing laws and policies is costly for health facilities. American policies on abortion economically impact health systems and facilities both domestically and abroad. Providing post-abortion care requires a disproportionate amount of health facility resources. The evidence base has consolidated around abortion costs to health systems and health facilities in high-income countries more than in low- or middle-income countries. Little is known about the economic impacts of abortion on communities or the mesoeconomics of abortion in the Middle East and North Africa. Methodologically, review papers are the most frequent study type, indicating that researchers rely on evidence from a core set of costing papers. Studies generating new primary data on mesoeconomic outcomes are needed to strengthen the evidence base.
Sections du résumé
BACKGROUND
Despite the high incidence of abortion around the globe, we lack synthesis of the known economic consequences of abortion care and abortion policies at the mesoeconomic level (i.e. health systems and communities). This scoping review examines the mesoeconomic costs, benefits, impacts, and values of abortion care and policies.
METHODS AND FINDINGS
Searches were conducted in eight electronic databases. We conducted the searches and application of inclusion/exclusion criteria using the PRISMA extension for Scoping Reviews. For inclusion, studies must have examined at least one of the following outcomes: costs, benefits, impacts, and value of abortion care or abortion policies. Quantitative and qualitative data were extracted for descriptive statistics and thematic analysis. Of the 150 included mesoeconomic studies, costs to health systems are the most frequently reported mesoeconomic outcome (n = 116), followed by impacts (n = 40), benefits (n = 17), and values (n = 11). Within health facilities and health systems, the costs of providing abortion services vary greatly, particularly given the range with which researchers identify and cost services. Financial savings can be realized while maintaining or even improving quality of abortion services. Adapting to changing laws and policies is costly for health facilities. American policies on abortion economically impact health systems and facilities both domestically and abroad. Providing post-abortion care requires a disproportionate amount of health facility resources.
CONCLUSIONS
The evidence base has consolidated around abortion costs to health systems and health facilities in high-income countries more than in low- or middle-income countries. Little is known about the economic impacts of abortion on communities or the mesoeconomics of abortion in the Middle East and North Africa. Methodologically, review papers are the most frequent study type, indicating that researchers rely on evidence from a core set of costing papers. Studies generating new primary data on mesoeconomic outcomes are needed to strengthen the evidence base.
Identifiants
pubmed: 33147223
doi: 10.1371/journal.pone.0237227
pii: PONE-D-20-01362
pmc: PMC7641432
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0237227Déclaration de conflit d'intérêts
We declare no competing interests.
Références
Obstet Gynecol. 2017 May;129(5):786-794
pubmed: 28383380
Eur J Obstet Gynecol Reprod Biol. 2002 Aug 5;104(1):43-8
pubmed: 12128261
Reprod Health Matters. 2009 May;17(33):120-32
pubmed: 19523589
Eur J Contracept Reprod Health Care. 2013 Dec;18(6):441-50
pubmed: 24033184
Int J Gynaecol Obstet. 2010 Feb;108(2):165-9
pubmed: 20035938
J Health Care Poor Underserved. 2014 Nov;25(4):1571-85
pubmed: 25418228
Health Care Anal. 2013 Dec;21(4):338-54
pubmed: 21948200
PLoS One. 2017 Apr 3;12(4):e0174615
pubmed: 28369061
Reprod Health Matters. 2004 Nov;12(24 Suppl):130-7
pubmed: 15938166
Afr J Reprod Health. 2013 Jun;17(2):118-28
pubmed: 24069757
J Adv Nurs. 1998 Jan;27(1):30-6
pubmed: 9515605
Int Fam Plan Perspect. 2003 Dec;29(4):182-7
pubmed: 14665427
BMJ Open. 2019 Jul 30;9(7):e029939
pubmed: 31366662
PLoS One. 2021 Jun 9;16(6):e0252005
pubmed: 34106927
BMC Health Serv Res. 2016 Oct 7;16(1):559
pubmed: 27717356
J Gynecol Obstet Biol Reprod (Paris). 2010 Nov;39(7):549-53
pubmed: 20570054
Afr J Reprod Health. 2009 Dec;13(4):73-80
pubmed: 20690275
Reprod Sci. 2017 May;24(5):731-737
pubmed: 27678099
Health Technol Assess. 2009 Nov;13(53):1-124, iii-iv
pubmed: 19906334
Health Policy Plan. 2017 Apr 1;32(3):305-313
pubmed: 27616307
Arch Gynecol Obstet. 2012 Nov;286(5):1161-4
pubmed: 22684851
Int Perspect Sex Reprod Health. 2010 Dec;36(4):197-204
pubmed: 21245026
BMC Public Health. 2011 Dec 06;11:904
pubmed: 22145859
BJOG. 2016 Aug;123(9):1489-98
pubmed: 26287503
Perspect Sex Reprod Health. 2010 Jun;42(2):79-86
pubmed: 20618746
J Health Popul Nutr. 2004 Dec;22(4):383-98
pubmed: 15663171
J Fam Plann Reprod Health Care. 2015 Jan;41(1):27-32
pubmed: 24563218
Cult Health Sex. 2018 May;20(5):560-573
pubmed: 28812525
Crit Public Health. 2016;26(1):77-87
pubmed: 27570376
J Med Chem. 2014 Jan 23;57(2):516-20
pubmed: 24328058
Reprod Health Matters. 2015 Feb;22(44 Suppl 1):125-33
pubmed: 25702076
Int J Gynaecol Obstet. 2012 Sep;118 Suppl 1:S28-32
pubmed: 22840267
Contraception. 2017 May;95(5):477-484
pubmed: 28232129
Health Policy Plan. 1996 Jun;11(2):117-31
pubmed: 10158454
Nurs Times. 2005 Apr 26-May 2;101(17):34-6
pubmed: 15881907
Reprod Health. 2012 Dec 22;9(1):34
pubmed: 23259660
J Fam Plann Reprod Health Care. 2007 Jul;33(3):199-202
pubmed: 17609081
Int J Gynaecol Obstet. 2012 Sep;118 Suppl 2:S134-40
pubmed: 22920617
Health Hum Rights. 2017 Jun;19(1):221-230
pubmed: 28630554
BMC Health Serv Res. 2016 Oct 22;16(1):612
pubmed: 27770797
Glob Public Health. 2017 Feb;12(2):236-249
pubmed: 26708223
Reprod Health Matters. 2005 Nov;13(26):25-34
pubmed: 16291483
Afr J Reprod Health. 2010 Jun;14(2):85-103
pubmed: 21243922
Contraception. 2003 Nov;68(5):345-51
pubmed: 14636938
Reprod Health Matters. 2005 Nov;13(26):93-100
pubmed: 16291490
Health Policy Plan. 2005 May;20(3):158-66
pubmed: 15840631
Int J Gynaecol Obstet. 2011 Jul;114(1):15-7
pubmed: 21575954
Womens Health (Lond). 2010 Nov;6(6):849-60
pubmed: 21118043
Fam Plann Perspect. 1995 Mar-Apr;27(2):54-9, 87
pubmed: 7796896
Soc Sci Med. 2007 May;64(9):1812-22
pubmed: 17355899
Int Fam Plan Perspect. 2008 Mar;34(1):40-50
pubmed: 18440916
PLoS One. 2018 Jun 28;13(6):e0197485
pubmed: 29953434
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Bull World Health Organ. 2000;78(5):580-92
pubmed: 10859852
BMC Health Serv Res. 2015 Dec 17;15:562
pubmed: 26677840
Contraception. 2015 Oct;92(4):339-44
pubmed: 26142621
PLoS One. 2021 Feb 18;16(2):e0246238
pubmed: 33600471
Harv Law Rev. ;130(1):397-406
pubmed: 28117562
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Contraception. 2007 Jan;75(1):45-51
pubmed: 17161124
Obstet Gynecol. 2017 Sep;130(3):616-624
pubmed: 28816736
PLoS One. 2018 Sep 21;13(9):e0204240
pubmed: 30240408
Stud Fam Plann. 2011 Sep;42(3):183-90
pubmed: 21972671
Perspect Sex Reprod Health. 2013 Dec;45(4):210-8
pubmed: 24188634
PLoS One. 2016 Jun 30;11(6):e0158645
pubmed: 27362270
Science. 2017 Oct 13;358(6360):175-176
pubmed: 29026035
BMC Med. 2018 Jun 14;16(1):88
pubmed: 29898742
Gynecol Obstet Invest. 2011;72(4):257-63
pubmed: 21997301
Soc Sci Med. 2018 Mar;200:199-210
pubmed: 29421467
Womens Health Issues. 2014 Jul-Aug;24(4):e419-24
pubmed: 24981401
Kathmandu Univ Med J (KUMJ). 2012 Jul-Sep;10(39):8-13
pubmed: 23434954
Toxicol Lett. 1992 Jan;60(1):61-8
pubmed: 1539182
Reprod Health Matters. 2015 Nov;23(46):169-76
pubmed: 26719008
Rev Panam Salud Publica. 2012 Dec;32(6):399-404
pubmed: 23370182
Gac Sanit. 2009 Sep-Oct;23(5):415-9
pubmed: 19264379
J Obstet Gynaecol Can. 2006 Feb;28(2):142-8
pubmed: 16643717
Obstet Gynecol. 2004 Apr;103(4):738-45
pubmed: 15051567
Perspect Sex Reprod Health. 2018 Mar;50(1):33-39
pubmed: 29443434
Int J Gynaecol Obstet. 1998 Dec;63 Suppl 1:S131-9
pubmed: 10075223
BJOG. 2009 May;116(6):768-79
pubmed: 19432565
Reprod Health Matters. 2005 Nov;13(26):44-53
pubmed: 16291485
Lancet. 1993 May 15;341(8855):1261-3
pubmed: 8098403
J Fam Plann Reprod Health Care. 2007 Oct;33(4):250-7
pubmed: 17925105
Am J Public Health. 2009 Apr;99(4):623-30
pubmed: 19197087
Contraception. 2014 Nov;90(5):496-501
pubmed: 25128413
J Pediatr Surg. 1976 Apr;11(2):267-8
pubmed: 1263071
Perspect Sex Reprod Health. 2003 Jan-Feb;35(1):16-24
pubmed: 12602753
Health Policy Plan. 2015 Mar;30(2):223-33
pubmed: 24548846
Womens Health Issues. 2018 May - Jun;28(3):212-218
pubmed: 29339010
J Fam Plann Reprod Health Care. 2006 Jan;32(1):19-22
pubmed: 16492328
Int Perspect Sex Reprod Health. 2009 Sep;35(3):114-21
pubmed: 19805016
PLoS One. 2021 May 6;16(5):e0250692
pubmed: 33956826
Reprod Health Matters. 2004 Nov;12(24):128-37
pubmed: 15626203